Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ptc Therapeutics (PTCT) Depreciation and Depletion (2016 - 2020)

Ptc Therapeutics has reported Depreciation and Depletion over the past 9 years, most recently at -$24.5 million for Q4 2020.

  • Quarterly results put Depreciation and Depletion at -$24.5 million for Q4 2020, down 34.53% from a year ago — trailing twelve months through Dec 2020 was $6.6 million (up 40.43% YoY), and the annual figure for FY2024 was $14.9 million, up 7.19%.
  • Depreciation and Depletion for Q4 2020 was -$24.5 million at Ptc Therapeutics, down from $11.6 million in the prior quarter.
  • Over the last five years, Depreciation and Depletion for PTCT hit a ceiling of $11.6 million in Q3 2020 and a floor of -$24.5 million in Q4 2020.
  • Median Depreciation and Depletion over the past 5 years was $3.4 million (2016), compared with a mean of $975000.0.
  • Peak annual rise in Depreciation and Depletion hit 1166.3% in 2017, while the deepest fall reached 1247.39% in 2017.
  • Ptc Therapeutics' Depreciation and Depletion stood at $823000.0 in 2016, then plummeted by 1247.39% to -$9.4 million in 2017, then crashed by 77.02% to -$16.7 million in 2018, then dropped by 8.9% to -$18.2 million in 2019, then crashed by 34.53% to -$24.5 million in 2020.
  • The last three reported values for Depreciation and Depletion were -$24.5 million (Q4 2020), $11.6 million (Q3 2020), and $10.2 million (Q2 2020) per Business Quant data.